PRINTER'S NO. 2565
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
312
Session of
2024
INTRODUCED BY SCHLOSSBERG, KINSEY, HILL-EVANS, SANCHEZ, HADDOCK,
MALAGARI, NEILSON, DALEY, KHAN AND DELLOSO, FEBRUARY 5, 2024
REFERRED TO COMMITTEE ON HEALTH, FEBRUARY 5, 2024
A RESOLUTION
Designating the week of May 5 through 11, 2024, as "Tardive
Dyskinesia Awareness Week" in Pennsylvania.
WHEREAS, Many people with serious mental health conditions,
such as bipolar disorder, major depressive disorder,
schizophrenia and schizoaffective disorder, or with
gastrointestinal disorders, including gastroparesis, upset
stomach, nausea and vomiting, may be treated with medications
that work as dopamine receptor blocking agents (DRBAs),
including antipsychotics and antiemetics; and
WHEREAS, While ongoing treatment with these medications can
be necessary, prolonged use is associated with tardive
dyskinesia (TD), an involuntary movement disorder that is
characterized by uncontrollable, abnormal and repetitive
movements of the face, torso, limbs, fingers or toes; and
WHEREAS, Even mild symptoms of TD can impact people
physically, socially and emotionally; and
WHEREAS, It is estimated that TD affects approximately
600,000 people in the United States and approximately 65% of
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18